Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Industry: Healthcare

Roswell Park Moving Unique Immunotherapy Platform Forward With $6.42 Million DoD Grant

Leave a comment


Drs. Shipra Gandhi and Pawel Kalinski will lead a Department of Defense-funded clinical trial assessing a three-pronged immunotherapy strategy for metastatic breast cancer.

Drs. Shipra Gandhi and Pawel Kalinski will lead a Department of Defense-funded clinical trial assessing a three-pronged immunotherapy strategy for metastatic breast cancer.

Our strategy uses a unique combination of biologic agents to make tumors visible to the immune system by making them look like tissue that’s been infected by a virus. Findings from earlier studies lend strong support for assessing this combination even in aggressive and hard-to-treat cancer types.


BUFFALO, N.Y. (PRWEB)

A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense (DoD) grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center. The four-year, $6.42 million Breakthrough Award (award no. W81XWH-19-1-0674/BC180510) through the DoD’s Breast Cancer Research Program will fund a clinical trial in patients with brain-metastatic breast cancer, to be led by Shipra Gandhi, MD, Assistant Professor of Oncology in the Department of Medicine at Roswell Park.

The phase II trial, slated to open in 2020, would be the first clinical study to assess the effectiveness of a three-pronged strategy combining distinct immunotherapy approaches:


  • A new dendritic-cell treatment vaccine developed by Dr. Kalinski and colleagues in collaboration with Brian Czerniecki, MD, PhD, Chair of the Breast Oncology Department at Moffitt Cancer Center in Tampa, Florida

  • Chemokine modulation using a combination proposed and validated by Dr. Kalinski as an optimized adjuvant for dendritic-cell vaccines, incorporating rintatolimod (brand name Ampligen) and interferon alfa-2b (brand name Intron A)

  • Immune checkpoint inhibition

Alone, these therapies are effective for a limited number of patients, but evidence suggests that together they may help break through a persistent challenge in oncology: how to turn “cold” tumors that don’t respond to existing therapies into “hot” ones that the immune system can be trained to recognize and pursue.

“A major limitation of cancer immunotherapy is that tumors adapt to naturally occurring effector cells by shutting down production of the relevant chemokines in the tumor microenvironment,” says Dr. Kalinski, the overall Principal Investigator for the project. “Our strategy uses a unique combination of biologic agents to make tumors visible to the immune system by making them look like tissue that’s been infected by a virus. We’ve never tested them all together before in patients, but the findings from earlier clinical and preclinical studies lend strong support for assessing this combination even in the most aggressive and hard-to-treat cancer types.”

Three key factors distinguish this platform for combination immunotherapy:

  • The approach is tumor-selective, meaning it can act preferentially to generate responses only in cancer tissues, but not in normal, noncancerous tissue

  • It selectively activates so-called “good” chemokines in the tumor microenvironment and promotes selective attraction of desirable tumor-fighting immune cells, but avoids activating “bad” chemokines that attract undesirable suppressive cells

  • These therapies have been shown in preclinical and clinical trials to be associated with low toxicity and few adverse side effects

The team will study this approach first in patients with localized brain-metastatic breast cancer (BMBC), or breast cancer that has begun to spread to the brain but is not yet widely disseminated. A companion clinical trial in patients with disseminated, leptomeningeal BMBC, to be led by Peter A. Forsyth, MD, Chair of the Neuro-Oncology Department at Moffitt Cancer Center, in collaboration with Dr. Czerniecki, partnering Principal Investigator on the project, will move forward with additional DoD funding of more than $8 million. Both trials will be available to patients at Roswell Park and at Moffitt.

“There are currently no curative treatments for breast cancer that has spread to and grown in the brain, and the options we have often involve significant side effects or harm to healthy tissues. So this is an area of pronounced clinical need,” notes Dr. Gandhi, Principal Investigator on the Roswell Park study. “We’re particularly encouraged to be developing a strategy that has the potential to be effective for patients with various breast cancer subtypes — cancers that are positive for HER2 markers as well as notoriously aggressive triple-negative breast cancers.”

Roswell Park has three other studies in progress assessing some of the component elements of this new therapeutic platform:

  • Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients with Colorectal Cancer Metastatic to the Liver (NCT03403634 – actively recruiting)

  • Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients with Prostate Cancer Before Surgery (NCT NCT03899987 – authorized by the FDA and Roswell Park’s Internal Review Board; not yet recruiting)

  • Chemokine Modulation Therapy and Pembrolizumab in Treating Participants with Metastatic Triple-Negative Breast Cancer (NCT NCT03599453 – actively recruiting)

AIM ImmunoTech Inc. has agreed to provide rintatolimod for the new DoD-funded studies in brain-metastatic breast cancer, as well as these ongoing studies.

Dr. Kalinski gratefully acknowledges earlier support for his work through donations to Roswell Park as a critical foundation that allowed him to pursue and attract outside funding for this work.

The new study in patients with BMBC is not yet open to accrual. For information about other clinical trials currently available at Roswell Park, please visit roswellpark.org/clinical-trials, call 1-800-ROSWELL (1-800-767-9355) or contact Roswell Park by email at askroswell@roswellpark.org.

This release is also available on the Roswell Park website: https://www.roswellpark.org/media/news/roswell-park-moving-unique-immunotherapy-platform-forward-642-million-dod-grant

Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.

Share article on social media or email:

Health

The New England Center for Children Announces Partnership with New School In Lebanon for Children with Autism

Leave a comment


https://www.prweb.com/

One Two Three Autism School, Beirut, Lebanon

“One Two Three Autism School’s partnership with NECC enables their staff and NECC-trained Lebanese teachers to provide the highest quality ABA therapy to Lebanese children,” said Saritta Trad, a co-founder and mother whose son attends the school.


SOUTHBOROUGH, Mass. (PRWEB)

The New England Center for Children® (NECC®), a global leader in autism education and research, announced today a partnership with One Two Three Autism School in Beirut, Lebanon, to serve children with autism and their families. NECC was contracted to manage school operations, teaching, applied behavior analysis (ABA) consulting, and professional development. One Two Three is the first and only school in Lebanon for children with autism.

“Autism treatment in much of the Middle East remains scarce, leaving thousands of children and families lacking resources,” said Vincent Strully, President and CEO of The New England Center for Children. “NECC is excited to bring proven, research-based ABA teaching practices to Lebanon through our management of One Two Three Autism School. Our growing international programs and services have reached 18 countries, bringing effective, evidence-based educational services to underserved children with autism and their families.”

“Autism services are sorely needed in Lebanon, as I experienced with my own son. The autism rate for children in Beirut and Mount Lebanon is one in 67,” said Saritta Trad, a co-founder and mother whose son attends the school. “For One Two Three Autism School, we turned to the world leaders in autism education. Our partnership with NECC enables their staff and NECC-trained Lebanese teachers to provide the highest quality ABA therapy, occupational therapy, and speech and language therapy to Lebanese children.”

“NECC is excited to be part of One Two Three Autism School and we look forward to helping transform the lives of children with autism and their families,” said Kristin Buchanan, NECC’s Global Consulting Director. “By empowering teachers worldwide with the knowledge and tools of ABA, together we can create more success stories like One Two Three.”

NECC Bringing Autism Education to Underserved Nations

NECC has helped thousands of children in the Middle East and worldwide through its centers, consulting services, and ACE® ABA Software System. In addition to Lebanon, NECC operates or consults in Kuwait City, Kuwait; Dubai and Abu Dhabi in the UAE; Doha, Qatar; Gurgaon, India; Riyadh and Dammam in Saudi Arabia; and in Brazil, Australia, Italy, England, Canada and other countries. The ACE Software is currently used in 13 countries. NECC employs close to 300 people internationally, a quarter of whom are U.S. citizens and the remaining are nationals. NECC employs more than 50 percent of the BCBAs in the entire Gulf Region.

An important part of NECC programs is the integration of local language and cultural and religious practices into the curriculum. Key to NECC’s mission is training and educating local staff to ensure knowledge transfer, program sustainability, and local growth of ABA programs. More schools and centers have followed suit in applying ABA practices, looking to achieve the results of NECC.

International Influence and Reach

Reflecting its worldwide reputation, NECC received the 2017 Award for International Dissemination of Behavior Analysis from the Society for the Advancement of Behavior Analysis (SABA), the peer academic organization of applied behavior analysis. The highly respected award is given to a person or organization demonstrating a significant and sustained contribution to the dissemination and development of ABA outside of the United States.

NECC’s professional development program has graduated many of the autism service industry’s leaders – teachers, behavior analysts, and researchers inside and outside of NECC whose training and dedication have helped thousands of children with autism and their families.

“The reach and influence of NECC are truly inspiring, and their impact in disseminating applied behavior analysis best practices,” said Dr. Maria Malott, CEO of the Association for Behavior Analysis International. “NECC has played a large part in making inroads for behavior analysis in the Middle East and worldwide.”

About One Two Three Autism School

The establishment of One Two Three Autism School was inspired by Bachir Sarkis and Saritta Trad, who were not able to find the appropriate education provider for their child in Lebanon. They wanted to build a school that could help provide quality services for their child as well as children in the community. Bachir’s uncle, Sarkis Sarkis, helped to fund the school and NECC services through a generous donation. One Two Three Autism School’s geographical location provides easy travel for families from other countries in the region. One Two Three Autism School hopes to provide an educational setting for Lebanese and other Middle Eastern citizens who are struggling to find an appropriate school for their children.

About The New England Center for Children

The New England Center for Children® (NECC®) is an award-winning autism education center and research institute. Our community of teachers, researchers, and clinicians have transformed the lives of thousands of children with autism worldwide through education, research, and technology. The Center provides comprehensive services to maximize independence: home-based, day, and residential programs, partner classrooms in public school systems, consulting services, the ACE® ABA Software System (http://www.acenecc.org), teacher professional development, and research on educational best practices.

NECC is committed to staff professional development, partnering with local colleges to provide on-site graduate training and degrees at little to no cost to the NECC teacher. The result is a growing pool of exceptional teachers trained in best-in-class methodologies, whether they continue their careers at NECC or move on to public schools or private agencies. The New England Center for Children is based in Southborough, MA, and operates a center in Abu Dhabi, UAE. Learn more at http://www.necc.org.

Industry: Healthcare

eClinical Solutions’ Dawn Kaminski Serves as Co-Chair again for SCDM 2019

Leave a comment


elluminate Data Central is reducing the time spent on data review and reconciliation activities by 30%, said Diane Lacroix, Director of Data Management at eClinical Solutions.


BOSTON (PRWEB)

As leaders in the clinical data management industry, eClinical Solutions team members were selected to participate in SCDM 2019 as the co-chair, session leaders and expert speakers. Hosted annually by the Society of Clinical Data Management, SCDM is the world’s premier data management conference and brings together 70 speakers to discuss data management advances and technologies that are driving clinical trials and regulatory standards. The 2019 SCDM Annual Meeting will take place in Baltimore, Maryland from September 29 to October 2.

“Data management is core to our business, which is why SCDM is so important to us,” says Katrina Rice, eClinical Solutions’ Executive Vice President of Professional Services. “It is essential to give the life sciences industry the right tools for accurate and timely data review and management. We are extremely proud to be involved in this world-class event.”

The eClinical Solutions team will be participating in a variety of thought leadership sessions, as well as a product showcase.

Clinical Data Management 2022, with Dawn Kaminski, Amy Nordo (Pfizer), Drew Garty (Veeva Systems) and session chair Dan Crawford (Veeva Systems), will explore areas where technology will have the greatest impact: data workbenches, integration of EDC and risk based monitoring, and eSource. Artificial Intelligence to Solve Clinical’s “Big Data” Challenges will bring together leaders in clinical data technology innovation, including eClinical Solutions’s CTO, Sam Anwar, eClinical Solutions’s CEO, Raj Indupuri, Catherine Celingant (Pfizer) and Jason Raines (Apellis) for a discussion on opportunities for data management transformation leveraging AI and machine learning. Diane Lacroix will chair a session on An Agile Approach to Data Management: Improving the End-to-End Clinical Data Strategy and will be joined by Julie Savoia, eClinical’s Manager of Data Management & Training, Professional Services, as well as Cecilia Calcagno (PRA Health Sciences) and Elizabeth Thompson (Sarepta Therapeutics). Finally, eClinical Solutions’s CEO, Raj Indupuri, and Chief Marketing Officer, Sheila Rocchio, will speak on how digital data strategies are being designed and implemented across R&D organizations during Roadmap to D-Clinical along with Deborah Lucas (Ra Pharmaceuticals) and Chris Jennings (Triverus Consulting). More information can be found on the SCDM conference website.

The product showcase will focus on the elluminate®️ platform and elluminate Data Central which is enabling next generation data review and management. Data managers use elluminate Data Central to view and manage all their clinical data from numerous sources and to automate formerly manual data review processes. The product showcase will highlight how elluminate Data Central is being used by data managers and medical monitors for incremental data review, query, issue and workflow management and for comprehensive data and medical review using interactive visual patient profiles.

“elluminate Data Central is reducing the time spent on data review and reconciliation activities by 30%,” said Diane Lacroix, Director of Data Management at eClinical Solutions. “We are excited about showcasing these new capabilities and providing use cases and examples to data managers about how this product can help increase productivity and improve overall data quality.”

Details:

Session 1 – Clinical Data Management 2022: A Glimpse Into the Future with Dawn Kaminski | Monday, September 30, 2019, 11:15 AM-12:15 PM

Session 9 – Roadmap to D-Clinical – Designing Your Digital Data Strategy with Raj Indupuri and Sheila Rocchio | Monday, September 30, 2019: 4:00 PM-5:30 PM

Session 6 – Artificial Intelligence to Solve Clinical’s “Big Data” Challenges with Raj Indupuri and Sam Anwar | Tuesday, October 1, 2019, 1:30 PM-3:00 PM

Session 17 – An Agile Approach to Data Management: Improving the End-to-End Clinical Data Strategy with Diane Lacroix and Julie Savoia | Tuesday, October 1, 11:30 AM – 12:30 PM

elluminate®️ Product Showcase | Tuesday, October 1, 9:30 AM-10:15 PM

About eClinical Solutions

eClinical Solutions is a leading provider of cloud based enterprise software and software-driven clinical data services. The elluminate® platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 100 life sciences companies on more than 500 trials. For more information, visit http://www.eclinicalsol.com.

Share article on social media or email:

Health

Truths and Misconceptions from Smile Atelier

Leave a comment



BEVERLY HILLS, Calif. (PRWEB)

Over the years, I have heard a lot of people outside of the dentistry world talk about veneers. Some positive and some negative. But nearly all that I hear is based on incorrect or an undeveloped understanding of exactly what they are and how they are created. I want to provide a resource where people can understand what they are and how they can benefit their smile.

Veneers Are Fragile

When people think of porcelain, tough and sturdy is not the first thought that comes to mind. This is a popular myth when it comes to veneers. In fact, porcelain veneers are designed very strong. Strong enough to withstand the same demands of natural teeth. Veneers in many cases can last longer than 20 years, so you can be assured they aren’t weak or fragile. Aluminum when in foil is very thin and easily broken, but, when it is designed for a car engine, it can also be quite sturdy and strong when engineered to be.

I Can Get Veneers and Forget About Maintenance

It is critical that you take good care of your teeth, whether they are natural teeth or veneers. A common issue for people who get veneers is oral care. You must still brush and floss your teeth two to three times per day. This will help make sure you get the full beautiful smile for the life of your veneers.

Veneers Look Fake

This is the number 1 complaint I hear about veneers. The truth is that porcelain veneers are used, specifically, because they reflect light in the same way that your natural teeth do. Veneer specialists know how to create a realistic looking tooth. They implement natural spaces and differing shapes to the porcelain veneers to create a natural looking smile. The dreaded chicklet tooth (square and uniform) is not something that you will get from a specialist. As long as you are seeing a specialist for your veneers, you should have no concerns with teeth that don’t look natural and beautiful.

With that being said…….

Any Dentist Can Place Veneers

As with any industry, Dentists have fields where they practice their expertise. You wouldn’t go to a dermatologist for open heart surgery right? Dentistry have experts in different focuses as well. There is an art to making veneers. Design is just as important as the specific placing of the veneers. Practice and experience are priceless with each veneer specialist. Make sure that you do your research to find the right veneer specialist for you.

Contact a Specialist to Find Out More

Most times, opinions on veneers are not rooted in facts. Information is free and accessible. Just reach out to someone near you who specializes in veneers, or you can reach out to myself to find out if veneers are right for you. Learn more about all cosmetic dentistry on my page http://www.labeverlyhillsdentist.com

*Dr Borzoo Ahmadi DDS is the preeminent expert in veneer design, creation, and placement for over a decade in Beverly Hills, CA.

Share article on social media or email:

Industry: Healthcare

AlayaCare Offers Deepest Integration to Medicaid Billing Through Partnership with Waystar Claims Management Solution

Leave a comment



TORONTO (PRWEB)

AlayaCare, a leading home care software provider, today announced the deepest Medicaid billing integration of its kind through a partnership with Waystar’s claims management solution. With this integration, home care agencies can increase operational efficiency and improve revenue performance, while remaining focused on providing quality care and improving patient outcomes.

“Billing, payment and claim management – these are important and complex functions for any home care agency particularly when the process is manual and paper-based,” said Neil Grunberg, VP Product, AlayaCare. “We offer a fully integrated electronic billing solution that simplifies the process. It streamlines workflows, improves staff productivity, and can mean higher claims revenue for agencies.”

AlayaCare, a cloud-based home healthcare platform for home and community care agencies, has fully integrated its electronic billing capabilities with Waystar’s revenue cycle technology. Waystar offers the industry’s highest-rated client service to more than 450,000 providers, 22,000 healthcare organizations and 750 health systems and hospitals.

“As a longtime partner of AlayaCare, Waystar is excited to help further simplify the revenue cycle and maximize revenue opportunities for home care agencies through this new integration,” said Matt Hawkins, Waystar CEO. “In a world of constantly changing reimbursement rules, providers need intelligent technology to help them get ahead of denials, reduce cost to collect, and bring in more revenue—so they can focus their resources on ever-better patient care.”

AlayaCare’s integration with Waystar facilitates a seamless claims process between providers and insurance payers. With Waystar, AlayaCare clients can pre-screen for claim errors, check insurance eligibility and consolidate and manage their electronic claims from a single location. This greatly simplifies the process, particularly when managing rejected claims. The electronic billing solution allows clients to make any needed corrections and re-submit within the software suite.

Electronic billing can help agencies maximize reimbursement, and in jurisdictions where banking is permitted, agencies can use the built-in tool to track partial hours to ensure that they receive funding for actual time spent providing care.

“There are agencies that are losing money because they aren’t tracking quarter or half units. They’re paying their caregivers, because the service was provided, but not billing for the time,” said Grunberg. “We appreciate that banking is not permitted in all states, but in places where it is, we want to help our clients maximize their revenue in the simplest, most efficient way.”

For more information about AlayaCare’s electronic billing capabilities and the value it offers to clients, visit the AlayaCare website here: http://www.alayacare.com

About AlayaCare

AlayaCare’s unique platform includes Back Office, Client and Family Portals, Remote Patient Monitoring, Telehealth, and Mobile Care Worker functionality in one integrated, highly robust and secure, cloud-based system. AlayaCare is providing the platform for Home and Community Care organizations to propel towards innovation and home care of the future. AlayaCare was founded in 2014. http://www.alayacare.com

About Waystar

Waystar provides next-generation, cloud-based technology that simplifies and unifies the healthcare revenue cycle. The Waystar platform removes friction in payment processes, streamlines workflows and improves financials for providers in every care setting. Waystar has scored Best in KLAS® every year since 2010 and earned multiple #1 rankings from Black Book™ surveys since 2012. The Waystar platform supports more than 450,000 providers, 750 health systems and hospitals, and 5,000 payers and health plans. For more information, visit waystar.com or follow @Waystar on Twitter.

For more information:

AlayaCare Media Enquiries: Amy Cole, amy@colecomms.ca, 647-287-0025

AlayaCare Client Enquiries: Brady Murphy, VP, Sales & Marketing, 647-477-4174 ext. 201

Share article on social media or email:

Health

Red Spot Interactive and Symplast Integrate their Software to Create a 360-Degree Patient Engagement Solution Driven by Practice ROI

Leave a comment


News Image

“We look forward to allowing our mutual practices to be smarter and faster with respect to ROI-driven patient acquisition and management,” said Jason Tuschman, CEO and founder of Red Spot Interactive.


JUPITER, Fla. (PRWEB)

Red Spot Interactive (RSI), a return on investment (ROI) driven patient acquisition and retention software platform supporting more than 30 medical practice management systems, has partnered with Symplast, the No. 1 mobile EHR/practice management system for plastic surgeons that delivers a HIPAA-secure cloud platform to more than 3,500 aesthetic users across the U.S. This partnership will give Symplast clients fully synchronized access to RSI’s patient acquisition, engagement, and retention software.

“Symplast has solved a difficult problem for aesthetic practices by creating a mobile-based PM platform for the fast-paced and dynamic aesthetic practice,” said Jason Tuschman, CEO and founder of Red Spot Interactive. “We appreciate the effort to solve such a problem, given our history, and look forward to allowing our mutual practices to be smarter and faster with respect to ROI-driven patient acquisition and management.”

“This is more than just a simple software integration; Symplast is excited to partner with Red Spot Interactive,” said Symplast CEO/CTO Facundo Formica. “Their robust ROI software delivers a tremendous need to our Symplast users regarding lead generation, analysis and full transparency between the very beginning of the patient journey throughout their entire lifecycle. This new integration reinforces the role that Symplast plays in aesthetic practices, serving as the data hub from which other ancillary, specialized softwares can seamlessly talk to in order to optimize a practice.”

The integration will allow Symplast clients to:

  • Track marketing revenue/ROI and key performance indicators associated with lead conversion, patient scheduling, and acquisition/retention, driving practice growth

  • Maintain 360-degree real-time patient engagement from appointment reminders and surveys to review generation and online reputation management

  • Create fully automated practice-specific patient lifecycle retention marketing based on predetermined patient interaction and practice goals, driving practice growth

  • Supply consumers with online appointment scheduling, reducing front desk workload and improving patient engagement

  • Track key performance indicators associated with website traffic and search engine rankings

  • Utilize HIPAA-compliant two-way texting with patients

Through Red Spot’s integration, Symplast customers will be able to manage the entire patient acquisition and retention process by return on investment while increasing practice scale and decreasing workload and vendor costs/touchpoints.

Share article on social media or email:

Industry: Healthcare

Virsys12 Selected as a Venture Atlanta 2019 Presenting Company

Leave a comment



ATLANTA (PRWEB)

Virsys12 announced on Monday that it has been chosen out of hundreds of applicants as one of the top 36 rising star technology companies in the Southeast that will present on stage at Venture Atlanta 2019. The 12th annual Venture Atlanta, the Southeast’s premier event for connecting technology innovation and investment capital, will be held October 16-17 in the heart of downtown Atlanta. With representation of over 200 national investor funds and an expected attendance of over 1,000 technology entrepreneurs, premier investors and key executives from across the country, Venture Atlanta has served as a launching pad for hundreds of companies over the past 12 years, connecting them with game-changing capital and opportunities to drive significant growth.

“We are honored to be selected to share the Virsys12 story of growth, transformational technologies and solutions for healthcare built on Salesforce at Venture Atlanta” said Tammy Hawes, Founder and CEO of Virsys12.

Virsys12 is a Salesforce AppExchange and Gold partner offering healthcare apps (V12 Network and V12 IPD “Intelligent Provider Directory”) and solutions that focus on the management of provider networks, contracts, and compliance for payers and health systems utilizing Salesforce Health Cloud and Heroku.

“With over $4.3 billion in funding awarded to date, Venture Atlanta has become the authority for recognizing technology innovation across the largest footprint in the Southeast, connecting the region’s best and brightest innovators with top-tier investors and other leaders in our technology ecosystem,” said Allyson Eman, executive director of Venture Atlanta. “This year, with over one-third of the presenting companies coming from outside Georgia, we’re thrilled to be showcasing the largest lineup yet, from emerging technologies to venture-stage companies that reflect our region’s incredible people, our innovation and continued opportunities for growth.”

During the two-day event, presenting companies and conference attendees will engage with regional as well as national venture capitalists, investors and other key players in the current technology landscape. The conference results in funding, national investor exposure and invaluable relationship-building with successful technology executives. In addition to hearing from the 36 presenting companies and lineup of over a dozen expert speakers, attendees will have an opportunity to network with over 40 selected Venture Atlanta “startup showcase companies” to watch that represent the most exciting emerging technologies in the Southeast. These innovators will be highlighted with dedicated tables at the conference to provide sneak peeks into their plans and products. Atlanta-based independent investment management firm, Invesco, is this year’s premier sponsor. Techstars will help kick off the conference on October 14 with Techstars Atlanta 2019 Demo Day in partnership with Cox Enterprises.

To learn more about Virsys12, visit http://www.virsys12.com. For additional information about Venture Atlanta, to register for the event or to view the conference schedule, please visit http://www.ventureatlanta.org.

About Venture Atlanta

Venture Atlanta, the Southeast’s technology innovation event, is where the region’s most promising tech companies meet the country’s top-tier investors. As the Southeast’s largest investor showcase helping launch more than 350 companies and raise over $4.3 billion in funding to date, Venture Atlanta connects the region’s top entrepreneurs with local and national venture capitalists, bankers, angel investors and others in the technology ecosystem who can help them raise the capital they need to grow their businesses. The annual nonprofit event is a collaboration of three leading Georgia business organizations: Atlanta CEO Council, Metro Atlanta Chamber and the Technology Association of Georgia (TAG). For more information, visit http://www.ventureatlanta.org. For updates, follow us on Twitter and visit our blog.

About Virsys12

Virsys12 is a healthcare technology company utilizing the Salesforce platform to provide scalable, flexible, and secure cloud-based solutions for payers and providers nationally. As a Salesforce AppExchange and Gold consulting partner, Virsys12 provides transformational healthcare solutions to meet the changing regulatory, reimbursement, and patient consumer trends within the industry. For more information, visit https://www.virsys12.com.

Share article on social media or email:

Health

ID Technology’s New Label Applicator Brings Enhanced Performance in a Small Package

Leave a comment


https://www.prweb.com/

ID Technology’s M2 Modular Label Applicator


FORT WORTH, Texas (PRWEB)

ID Technology, a product brand of ProMach, introduces the M2 Labeling Head, a new generation of the M-Series. The M2 is a modular wipe-on high-speed label applicator with faster performance, increased accuracy, and expanded capabilities, and it will be exhibited for the first time at Pack Expo 2019, September 23-25, in the Las Vegas Convention Center.

While providing a 4.3-inch color touchscreen HMI and new onboard controls, the M2 Labeling Head remains more compact than its competition. This allows for it to fit where other labelers can’t. The modular labeler can be mounted in any orientation to apply labels to the top, bottom, and sides of customer products or containers. The simple to use onboard HMI can be programmed to hold multiple recipes that can easily be recalled for rapid and repeatable product changeovers.

The M2’s flexibility allows it to be used as a standalone labeling head on a support stand, integrated into a host machine or as part of one of ID Technology’s comprehensive range of turn-key prime labeling systems. By using less parts, the M2 reduces the equipment’s complexity while saving time and money. A new label sensor bracket plate design accommodates both an ID Technology high-speed photoelectric label sensor as well as a high-speed ultrasonic transparent label sensor. It is a quick and easy swap between either sensor type. The M2 is also compatible with a broad range of date/lot coding technologies including, thermal transfer overprinters (TTO), inkjet coders, laser coders and other coding devices.

The M2 comes with many enhancements that allow this labeling head to run smoother than ever before. The M2 is powered by a new stepper motor with closed loop encoder and controls to enhance performance with continuous accuracy. The newly designed web drive offers several advantages including enhanced safety, better ergonomics, easy loading, increased grip, and lower inertia. An additional wiper has been added to provide better tension control of the liner as it travels through the labeler, and the new standard ball-bearing web rollers create less tension in the system. A newly developed and enhanced finishing brush assembly provides a cleaner and more durable brush, used for smoothing out each label.

The guarded nip drive assembly is standard and has been upgraded. Not only is it easier to open because of the protruding lever, the lever is also red, making an open nip more noticeable. Additionally, the new lever is more durable and requires less force to open. The M2 drive roller has better grip and is made of longer lasting material.

The M2’s durability, flexibility, and high-speed capabilities make this next generation model a superior label applicator. Check out the new M2 modular label applicator and many other innovative print, label, and coding solutions ID Technology has to offer at Pack Expo 2019, booth #C-3225. Or, find additional information online at http://www.IDTechnology.com.

About ID Technology

Customers across North America depend on ID Technology to design, build, integrate, and install the most effective product, case, and pallet identification systems for their product lines. ID Technology is a leading provider of labeling, coding, and marking equipment that also supplies quality flexographic, digital, blank, and shell labels in run volumes of any size from numerous regional label converting facilities across North America. ID Technology is a product brand of ProMach, a global leader in packaging line solutions. As part of the ProMach Labeling & Coding business line, ID Technology helps our packaging customers protect their reputation and grow the trust of their consumers. ProMach is performance, and the proof is in every package. Learn more about ID Technology at http://www.IDTechnology.com.

About ProMach

ProMach is a family of best-in-class packaging solution brands serving manufacturers of all sizes and geographies in the food, beverage, pharmaceutical, personal care, and household and industrial goods industries. ProMach brands operate across the entire packaging spectrum: filling and capping, flexibles, pharma, product handling, labeling and coding, and end of line. ProMach also provides Performance Services, including integrated solutions, design/build, engineering services, and productivity software to optimize packaging line design and deliver maximum uptime.

ProMach designs, manufactures, integrates, and supports the most sophisticated and advanced packaging solutions in the global marketplace. Its diverse customer base, from Fortune 500 companies to smaller, privately held businesses worldwide, depends on reliable, flexible, technologically advanced equipment and integrated solutions. ProMach is headquartered near Cincinnati, Ohio, with manufacturing facilities and offices throughout the United States, Canada, Mexico, Brazil, Europe, United Arab Emirates, and China. For more information about ProMach, visit http://www.ProMachBuilt.com.

Share article on social media or email:

Industry: Healthcare

Fire Equipment Manufacturers’ Association Releases Whitepaper on Pressure-Reducing Valves

Leave a comment


Understanding how pressure-reducing valves work and how they are regulated is key to keeping buildings safe. It will also help fire protection engineers and building owners select and adjust their PRVs, which is why the information contained in this newly released whitepaper is so valuable.


CLEVELAND (PRWEB)

Fire Equipment Manufacturers’ Association just released a new whitepaper entitled ‘The Ins & Outs of Pressure-Reducing Valves’. The non-profit trade association encourages building managers and fire protection engineers to download and read the whitepaper to learn more about PRV standards and operation instructions.

Most high-rise projects are required by regulations to have automatic sprinkler systems as well as standpipe systems for use by fire departments. In such buildings, installing pressure-reducing valves on each floor can ensure that the pump pressure on the lower floors does not exceed standards established by the National Fire Protection Association while still allowing the minimum acceptable pressure to the top floors. The whitepaper released by Fire Equipment Manufacturer’s Association spells out the requirements and standards for PRVs.

“Understanding how pressure-reducing valves work and how they are regulated is key to keeping buildings safe. It will also help fire protection engineers and building owners select and adjust their PRVs, which is why the information contained in this newly released whitepaper is so valuable,” said Jeff Saunders, president of Fire Equipment Manufacturers’ Association. The whitepaper is based on a previously-written article the association updated with current information and is being published with permission from the original author.

Building managers, fire protection engineers and other interested parties are invited to read, study and download the whitepaper at https://femalifesafety.org/prv-whitepaper.html. Additional information about Fire Equipment Manufacturers’ Association can be found at https://femalifesafety.org/.

About the Fire Equipment Manufacturers’ Association

The Fire Equipment Manufacturers’ Association is a more than 80-year-old international non-profit trade association dedicated to saving lives and protecting property by providing education of a balanced fire protection design. For additional information, including videos, interactive questionnaires and training websites about fire safety and protection, visit http://www.femalifesafety.org or call 216-241-7333. For a complete listing of member companies, visit the Member Profiles page of the association’s website at http://www.femalifesafety.org/membership.html.

Share article on social media or email:

Health

Leading Bellevue Medspa A-to-Zen Cosmetic Surgery & Aesthetics Announces New Name and Convenient, New Location

Leave a comment


Dr. John Bullis, double board-certified cosmetic surgeon , has changed the name and location of his acclaimed medspa to enhance patient experience and better promote his extensive range of services.


BELLEVUE, Wash. (PRWEB)

Newly named A-to-Zen Cosmetic Surgery & Aesthetics, a leading medical spa in Bellevue, Washington, has moved to a new location at 1260 116th Ave., NE, Suite 100, Bellevue, WA; the phone number will remain the same: 425.615.6307.

Owner, medical director, and cosmetic surgeon of A-to-Zen Cosmetic Surgery & Aesthetics, double board-certified Dr. John Bullis, has changed the name and location of his medspa to enhance patient experience and better promote his extensive range of services. Dr. Bullis is proud to offer his esteemed patients in Bellevue and beyond the highest level of both plastic surgery and non-surgical aesthetic treatments.

“The new space is more luxurious and spa-like in its decor and feel,” says Dr. Bullis. What’s more, “…the new office has much better parking!”

Dr. Bullis is a seasoned cosmetic surgeon who uses advanced techniques to deliver optimal results with minimal discomfort and downtime. For example, he performs “Weekend Tummy Tucks” when appropriate using the Avelar Technique, which involves smoothing and flattening the belly without separating skin from muscle, a process that minimizes trauma to the body while dramatically enhancing the patient experience.

Dr. Bullis also proudly offers the leading non-surgical aesthetic and body contouring treatments — from platelet-rich plasma (PRP) to non-invasive fat reduction — to help patients achieve their cosmetic goals with little to no downtime. To learn more about A-to-Zen Cosmetic Surgery & Aesthetics, please call 425.615.6307 to schedule a personal consultation today.

About A-to-Zen Cosmetic Surgery & Aesthetics

A-to-Zen Cosmetic Surgery & Aesthetics comprises a team of dedicated medical professionals who are committed to helping you look and feel your absolute best for total body vitality. Offering a holistic approach, A-to-Zen’s mission is to maximize the quality of life for patients by offering a blend of traditional and alternative medicine and a comprehensive range of both surgical and non-surgical treatments, including platelet-rich plasma (PRP) facial rejuvenation, PRP hair restoration, PRP for sexual health, PRP-enhanced fat transfer, truSculpt® 3D non-invasive fat removal, liposuction, breast augmentation, tummy tuck, labiaplasty, IV hydration therapy, Botox®, dermal fillers, ThermiVa® non-surgical vaginal rejuvenation, Sculpsure® non-invasive fat reduction, ThermiSmooth® non-invasive skin tightening, bio-identical hormone replacement therapy, medically-supervised weight loss, nutritional therapy, chemical peels, facials, acne treatments, and more.

About Dr. John Bullis

Owner and medical director of A-to-Zen Cosmetic Surgery & Aesthetics, Dr. John Bullis is board-certified by the American Board of Obstetrics and Gynecology (ABOG) and the American Board of Cosmetic Surgery (ABCS). Dr. Bullis has performed thousands of cosmetic surgical procedures and is an expert at both surgical and non-surgical body sculpting.

Dr. Bullis attended undergraduate and medical school at Georgetown University and obtained a Master’s Degree in physiology at the University of Maryland at Baltimore. Dr. Bullis served in the U.S. Army at Ft. Lewis, Washington, Fort Belvoir, Virginia, and Walter Reed Army Medical Center, in Washington, D.C., where he honed his surgical skills and specialized in urogynecology, pelvic reconstructive surgery, and minimally invasive gynecologic surgery.

Dr. Bullis is a Fellow of the American Academy of Cosmetic Surgeons (AACS), the American Congress of Obstetricians and Gynecologists (ACOG), the American Academy of Anti-Aging Medicine (A4M), the American Urogynecologic Society (AUGS), and the Obesity Medicine Association (OMA).

Share article on social media or email: